Speakers
James McLaughlin is president, CEO and co-founder of Gemini Therapeutics, and has led the company since its inception in 2015. James has a background in…
Read MoreDr. Hoffman has been Chief Executive Officer of Aerpio Pharmaceuticals since December 2017. Prior to Aerpio, Dr. Hoffman was a Senior Advisor to PDL BioPharma,…
Read MoreMiki Kapoor is CEO of Verana Health. With two decades of diverse experience in healthcare, in operations, finance, strategy and policy, Miki has a notably…
Read MoreDr. Franziska Ullrich pursued her B.Sc. and M.Sc. in mechanical engineering and robotics at ETH Zurich in Switzerland and gained complementary experience during practical work…
Read MoreJill leads Ophthalmology in Personalized Health Care at Roche-Genentech. She oversees and coordinates all efforts in the development of meaningful data at scale and advanced…
Read MoreOmar R. Sadruddin, MD currently serves as Santen’s Global Medical Director for the Surgical Glaucoma business. Dr. Sadruddin brings a deep knowledge of ophthalmic devices…
Read MoreJehan Tamboowalla, is currently VP, Head of New Products, Ophthalmology at Novartis. Jehan brings more than 20 years of Product Launch, Commercial, and R&D experience…
Read MoreAnthony B. Daniels, M.D., M.Sc., is Assistant Professor of Ophthalmology and Visual Sciences and the Director of Ocular Oncology at the Vanderbilt Eye Institute and…
Read MoreDr. Antonetti received his PhD in Cellular and Molecular Biology at The Penn State College of Medicine under the direction of Dr. Leonard Jim Jefferson…
Read MoreMy scientific interests are to develop and deploy new functional imaging tools to image the cellular pathology and progression of vascular disease in the eye.…
Read MoreChristina Y. Weng, MD, MBA is a tenured Professor and Alice R. McPherson Retina Research Foundation Chair in Ophthalmology at Baylor College of Medicine. Dr.…
Read MoreBrian F. Hofland, Ph.D., is President of Research to Prevent Blindness (RPB), a charitable, non-profit organization located in New York City, that funds academic early-stage…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.